Company Filing History:
5 out of 164 
1 out of 38 
Years Active: 2004-2013
Title: Innovations by Inventor Mario Ehlers
Introduction
Mario Ehlers is a notable inventor based in Lincoln, NE (US), recognized for his contributions to medical technology. He holds a total of 5 patents that focus on advancements in cardiac treatment and management. His work has significant implications for patients suffering from heart conditions.
Latest Patents
One of Ehlers' latest patents is titled "Treatment of hibernating myocardium with an exendin peptide." This invention addresses the issue of hibernating myocardium, which is characterized by viable myocardium with impaired function due to localized reduced perfusion. The invention highlights the role of GLP-1 in reducing plasma norepinephrine levels, making it useful for treating hibernating myocardium or diabetic cardiomyopathy. Another significant patent is the "Method of performing angioplasty with a GLP-1 molecule." This method involves treating patients suffering from acute coronary syndrome, optimizing metabolism in cardiac tissue, and preventing cardiac damage associated with ischemia.
Career Highlights
Throughout his career, Mario Ehlers has worked with prominent companies in the pharmaceutical industry, including Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed to his innovative approach to cardiac treatment.
Collaborations
Ehlers has collaborated with notable individuals in his field, including Thomas R. Coolidge. These collaborations have likely enhanced the development and implementation of his patented technologies.
Conclusion
Mario Ehlers is a distinguished inventor whose work in cardiac treatment has the potential to improve patient outcomes significantly. His innovative patents reflect his commitment to advancing medical technology and addressing critical health issues.